Gene · 8215
DVL1P1: dishevelled segment polarity protein 1 pseudogene 1
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. DVL1P1: dishevelled segment polarity protein 1 pseudogene 1. Genes, record 8215. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8215
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P54792 | Putative segment polarity protein dishevelled homolog DVL1P1 | 670 | 0 | HGNC |
Source UniProt
Patents2
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,082
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DVL1P1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| R01EY013256 | Retinal Patterning During Eye Development | 8 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P40OD018537 | Bloomington Drosophila Stock Center at Indiana University | 4 | 2025 |
| R35GM122530 | Lipid regulation of cellular signaling and protein-protein interactions | 4 | 2025 |
| R35GM127103 | Wnt/Frizzled-PCP signaling in development and disease | 4 | 2025 |
| P30CA196521 | The Tisch Cancer Institute - Cancer Center Support Grant | 3 | 2025 |
| R35GM118096 | Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis | 3 | 2025 |
1 to 10 of 1,082Source NIH's project files
See all 1,082 nih grantsPapers1,958
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequently amplified SHANK2 promotes esophageal squamous cell carcinoma progression through the DVL/YAP axis. | Oncogene | 2026 | 42675223 | PubTator, text mining | PubMed |
| Direct β-arrestin engagement by the non-canonical WNT receptor FZD6 via a shallow binding pocket. | Acta Pharmacol Sin | 2026 | 42608530 | PubTator, text mining | PubMed |
| GPCRs interaction with LGR5: Implications to cancer stemness. | J Cancer | 2026 | 42577862 | PubTator, text mining | PubMed |
| NKD1 promotes the progression and 5-FU resistance of colorectal cancer via the Wnt/β-catenin signaling. | Cell Death Dis | 2026 | 42431857 | PubTator, text mining | PubMed |
| Unravelıng non-canonıcal Wnt sıgnalıng ın neural development and dısorders: a revıew of Wnt/PCP and Wnt/ca²⁺ pathways. | Mol Biol Rep | 2026 | 42268489 | PubTator, text mining | PubMed |
| IGFBP4 suppresses EndMT and preserves rabbit corneal endothelial cell phenotypes by inhibiting the Wnt2/β-catenin signaling pathway. | Exp Eye Res | 2026 | 42248388 | PubTator, text mining | PubMed |
| Dishevelled-mediated clustering stabilizes Frizzled6 and Vangl2 to establish planar cell polarity in the mammalian skin. | bioRxiv | 2026 | 42146357 | PubTator, text mining | PubMed |
| A Wnt-induced conformational phospho-switch in DVL3 controls association with Frizzled receptors and Wnt/β-catenin signaling. | Sci Adv | 2026 | 42127203 | PubTator, text mining | PubMed |
| Dishevelled PDZ domain targeting peptides modulate non-canonical Wnt5a/Ror signaling. | Biochem Biophys Rep | 2026 | 42094294 | PubTator, text mining | PubMed |
| Alveolar Bone Regeneration: Smart Biomaterials and Physical Stimulation. | J Biomed Mater Res B Appl Biomater | 2026 | 42032797 | PubTator, text mining | PubMed |
1 to 10 of 1,958
See all 1,958 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8215
GET https://conductscience.org/api/genes/v1/8215/grants?page=2